Role of RajaswalacharyaOn different patterns of menstrual cycle

Phase 2

Not yet recruiting

Conditions: Diseases of the genitourinary system. Ayurveda Condition: ARTAVAVAHASROTOVIKARAH, (2) ICD-10 Condition: N921||Excessive and frequent menstruation with irregular cycle,

Brief Summary: 1. Subjects of age group 18 to 45 years complaining of chief complaint of dysmenorhoea/ abnormal uterine bleeding (AUB)/ oligomenorrhoea.

2. Subjects suffering with dysmenorhoea/ abnormal uterine bleeding (AUB)/ oligomenorrhoea for 2 consecutive cycles.

**For Group - A**: dysmenorhoea with scanty or average amount of menses

**For Group - B**: Heavy menstrual bleeding (amount >80ml) or

Prolonged menstrual bleeding (duration >7 days) or

Frequent menstrual cycle (interval< 21 days)

**For Group C -** Oligomenorrhoea: Interval between 2 cycle exceeding more than 35 days but not more than 50 days

Recruitment & Eligibility

Inclusion Criteria

1.Subjects of age group 18 to 45 years complaining of chief complaint of dysmenorhoea/ abnormal uterine bleeding (AUB)/ oligomenorrhoea. 2.Subjects suffering with dysmenorhoea/ abnormal uterine bleeding (AUB)/ oligomenorrhoea for 2 consecutive cycles. For Group.
A: dysmenorhoea with scanty or average amount of menses For Group.
B: Heavy menstrual bleeding (amount >80ml) or Prolonged menstrual bleeding (duration >7 days) or Frequent menstrual cycle (interval< 21 days) For Group C.
Oligomenorrhoea: Interval between 2 cycle exceeding more than 35 days but not more than 50 days.

Exclusion Criteria

1.Subjects suffering from venereal diseases. 2.Subjects suffering from systemic diseases. 3.Subjects having organic pathology of uterus and adnexae eg. Fibroid uterus.
size of fibroid less than 2 cm. 4.Subjects using intra uterine contraceptive devices. 5.Subjects with H/O hypothyroidism and hyperthyroidism with DUB. 6.Pregnant women. 7.Patients having bleeding due to abortion. 8.Patients having bleeding after menopause. 9.Patients having coagulation disorders. 10.Any type of malignancy. 11.Drug induced amenorrhoea/oligomenorrhoea/ abnormal uterine bleeding (AUB) 12.Patients taking OCPs 13.Patient having congenital and structural abnormality of uterus. 14.Haemoglobin less than 9 gm%.

Primary Outcome Measures

Name	Time	Method
To check the effectiveness of Rajaswala charya in the management of different patterns of menstrual cycle	20 weeks

Secondary Outcome Measures

Name	Time	Method
To develop standard protocol of Rajaswala charya.	2 To conduct a survey of the prevalence and incidence of different patterns of menstrual cycle.

Locations (1): National Insitute Of Ayurveda
🇮🇳
Jaipur, RAJASTHAN, India
National Insitute Of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Hetal H Dave
Principal investigator
9251758867
hetaldave2406@gmail.com